| Authors: |
Replogle JM; Medical Scientist Training Program, University of California, San Francisco, San Francisco, United States.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States.; Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, United States.; Whitehead Institute for Biomedical Research, Cambridge, United States., Bonnar JL; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States.; Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, United States.; Whitehead Institute for Biomedical Research, Cambridge, United States., Pogson AN; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States.; Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, United States.; Whitehead Institute for Biomedical Research, Cambridge, United States., Liem CR; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States., Maier NK; Department of Microbiology, Harvard Medical School, Boston, United States., Ding Y; Department of Microbiology, Harvard Medical School, Boston, United States., Russell BJ; Department of Microbiology, Harvard Medical School, Boston, United States., Wang X; Department of Microbiology, Harvard Medical School, Boston, United States., Leng K; Medical Scientist Training Program, University of California, San Francisco, San Francisco, United States.; Institute for Neurodegenerative Disease, University of California, San Francisco, San Francisco, United States., Guna A; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States.; Whitehead Institute for Biomedical Research, Cambridge, United States., Norman TM; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States., Pak RA; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States., Ramos DM; Center for Alzheimer's Disease and Related Dementias, National Institutes of Health, Bethesda, United States.; National Institute on Aging, National Institutes of Health, Bethesda, United States., Ward ME; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, United States., Gilbert LA; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States.; Department of Urology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, United States.; Arc Institute, Palo Alto, United States., Kampmann M; Institute for Neurodegenerative Disease, University of California, San Francisco, San Francisco, United States.; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States., Weissman JS; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States.; Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, United States.; Whitehead Institute for Biomedical Research, Cambridge, United States.; Department of Biology, Massachusetts Institute of Technology, Cambridge, United States.; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, United States., Jost M; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States.; Department of Microbiology, Harvard Medical School, Boston, United States. |
